259 related articles for article (PubMed ID: 27770477)
1. IgE and allergen-specific immunotherapy-induced IgG
Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
[TBL] [Abstract][Full Text] [Related]
2. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
4. Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.
Seutter von Loetzen C; Reuter A; Spiric J; Schulenborg T; Bellinghausen I; Völker E; Vogel L; Rösch P; Schiller D
Clin Exp Allergy; 2019 May; 49(5):712-723. PubMed ID: 30706562
[TBL] [Abstract][Full Text] [Related]
5. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
6. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
8. Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G; Smolnikov E; Litovkina A; Jiang T; Shatilov A; Tulaeva I; Tulaev M; Karaulov A; Poroshina A; Zhernov Y; Focke-Tejkl M; Weber M; Akinfenwa O; Elisyutina O; Andreev S; Shilovskiy I; Shershakova N; Smirnov V; Fedenko E; Lepeshkova TS; Beltyukov EC; Naumova VV; Kundi M; Khaitov M; Wiedermann U; Valenta R; Campana R
Allergy; 2023 Dec; 78(12):3136-3153. PubMed ID: 37701941
[TBL] [Abstract][Full Text] [Related]
9. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.
Husslik F; Hanschmann KM; Krämer A; Seutter von Loetzen C; Schweimer K; Bellinghausen I; Treudler R; Simon JC; Vogel L; Völker E; Randow S; Reuter A; Rösch P; Vieths S; Holzhauser T; Schiller D
PLoS One; 2015; 10(7):e0132956. PubMed ID: 26186356
[TBL] [Abstract][Full Text] [Related]
10. Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
Campana R; Vrtala S; Maderegger B; Dall'Antonia Y; Zafred D; Blatt K; Herrmann H; Focke-Tejkl M; Swoboda I; Scheiblhofer S; Gieras A; Neubauer A; Keller W; Valent P; Thalhamer J; Spitzauer S; Valenta R
Mol Immunol; 2011 Jan; 48(4):431-41. PubMed ID: 21093057
[TBL] [Abstract][Full Text] [Related]
11.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
12. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
14. Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy.
Gepp B; Lengger N; Bublin M; Hemmer W; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2014 Jul; 134(1):188-94. PubMed ID: 24529686
[TBL] [Abstract][Full Text] [Related]
15. Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
Asam C; Batista AL; Moraes AH; de Paula VS; Almeida FC; Aglas L; Kitzmüller C; Bohle B; Ebner C; Ferreira F; Wallner M; Valente AP
Clin Exp Allergy; 2014 Aug; 44(8):1083-93. PubMed ID: 24979350
[TBL] [Abstract][Full Text] [Related]
16. Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination.
Vrtala S; Fohr M; Campana R; Baumgartner C; Valent P; Valenta R
Vaccine; 2011 Mar; 29(11):2140-8. PubMed ID: 21215346
[TBL] [Abstract][Full Text] [Related]
17. Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.
Mikus M; Zandian A; Sjöberg R; Hamsten C; Forsström B; Andersson M; Greiff L; Uhlén M; Levin M; Nilsson P; van Hage M; Ohlin M
J Allergy Clin Immunol; 2021 Mar; 147(3):1077-1086. PubMed ID: 32791163
[TBL] [Abstract][Full Text] [Related]
18. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
19. Isotype-specific binding patterns of serum antibodies to multiple conformational epitopes of Bet v 1.
Schmalz S; Mayr V; Shosherova A; Gepp B; Ackerbauer D; Sturm G; Bohle B; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2022 May; 149(5):1786-1794.e12. PubMed ID: 34740603
[TBL] [Abstract][Full Text] [Related]
20. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System.
Movérare R; Elfman L; Vesterinen E; Metso T; Haahtela T
Allergy; 2002 May; 57(5):423-30. PubMed ID: 11972482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
